Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Cataract
Interventions
DRUG

Acular, Xibrom

"1. Acular 5ml (in the eye)Instill one drop into the eye to be operated on four times a day at (6am, 12pm, 6pm, 12am)~2. Xibrom 5ml (in the eye) Instill one drop into the eye to be operated on two times a day (8am and 8pm)"

Trial Locations (1)

18702

Bucci Laser Vision Institute and Ambulatory Surgery Center, Wilkes-Barre

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Innovative Medical

INDUSTRY